196 related articles for article (PubMed ID: 15553070)
1. [Ribavirin--pharmacological features, antiviral effects against hepatitis C virus (HCV) and other viruses and side effects during treatment].
Wawrzynowicz-Syczewska M
Przegl Epidemiol; 2002; 56 Suppl 5():35-40. PubMed ID: 15553070
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of action of ribavirin in antiviral therapies.
Tam RC; Lau JY; Hong Z
Antivir Chem Chemother; 2001 Sep; 12(5):261-72. PubMed ID: 11900345
[TBL] [Abstract][Full Text] [Related]
3. Ribavirin up-regulates the activity of double-stranded RNA-activated protein kinase and enhances the action of interferon-alpha against hepatitis C virus.
Liu WL; Su WC; Cheng CW; Hwang LH; Wang CC; Chen HL; Chen DS; Lai MY
J Infect Dis; 2007 Aug; 196(3):425-34. PubMed ID: 17597457
[TBL] [Abstract][Full Text] [Related]
4. Ribavirin in the treatment of hepatitis C.
Abonyi ME; Lakatos PL
Anticancer Res; 2005; 25(2B):1315-20. PubMed ID: 15865084
[TBL] [Abstract][Full Text] [Related]
5. Mechanism of action of ribavirin in the combination treatment of chronic HCV infection.
Lau JY; Tam RC; Liang TJ; Hong Z
Hepatology; 2002 May; 35(5):1002-9. PubMed ID: 11981750
[No Abstract] [Full Text] [Related]
6. Treating HCV with ribavirin analogues and ribavirin-like molecules.
Gish RG
J Antimicrob Chemother; 2006 Jan; 57(1):8-13. PubMed ID: 16293677
[TBL] [Abstract][Full Text] [Related]
7. Viral interaction and responses in chronic hepatitis C and B coinfected patients with interferon-alpha plus ribavirin combination therapy.
Chuang WL; Dai CY; Chang WY; Lee LP; Lin ZY; Chen SC; Hsieh MY; Wang LY; Yu ML
Antivir Ther; 2005; 10(1):125-33. PubMed ID: 15751770
[TBL] [Abstract][Full Text] [Related]
8. [The adherence in the treatment of chronic hepatitis C].
Pawłowska M; Halota W
Pol Merkur Lekarski; 2005 Apr; 18(106):469-72. PubMed ID: 16161937
[TBL] [Abstract][Full Text] [Related]
9. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of chronic viral hepatitis].
Pedersen C; Pedersen CR
Ugeskr Laeger; 2008 Jun; 170(24):2137-40. PubMed ID: 18565297
[TBL] [Abstract][Full Text] [Related]
11. Prospects for hepatitis C virus therapeutics: levovirin and viramidine as improved derivatives of ribavirin.
Watson J
Curr Opin Investig Drugs; 2002 May; 3(5):680-3. PubMed ID: 12090539
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of antiviral activity against hepatitis C virus in vitro by interferon combination therapy.
Okuse C; Rinaudo JA; Farrar K; Wells F; Korba BE
Antiviral Res; 2005 Jan; 65(1):23-34. PubMed ID: 15652968
[TBL] [Abstract][Full Text] [Related]
13. [Interferon-alpha and ribavirin combination therapy for co-infection of hepatitis C virus and human immunodeficiency virus].
Zheng YH; He Y; Yang X; Gong GZ; Zhou HY; Zhang CY; Zhou W; Huang L; Ding PP; Li H
Zhonghua Gan Zang Bing Za Zhi; 2005 Oct; 13(10):741-4. PubMed ID: 16248945
[TBL] [Abstract][Full Text] [Related]
14. [Novel mode of action of ribavirin (Rebetol), a drug for the treatment of chronic hepatitis C: inducting the mutation of RNA viruses].
Ogawa M; Morisada A
Nihon Yakurigaku Zasshi; 2002 Dec; 120(6):398-408. PubMed ID: 12528471
[TBL] [Abstract][Full Text] [Related]
15. Combination therapy with ribavirin and amantadine in renal transplant patients with chronic hepatitis C virus infection is not superior to ribavirin alone.
Calanca LN; Fehr T; Jochum W; Fischer-Vetter J; Müllhaupt B; Wüthrich RP; Ambühl PM
J Clin Virol; 2007 May; 39(1):54-8. PubMed ID: 17409018
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic evaluation of the effects of ribavirin on zidovudine triphosphate formation: ACTG 5092s Study Team.
Aweeka FT; Kang M; Yu JY; Lizak P; Alston B; Chung RT;
HIV Med; 2007 Jul; 8(5):288-94. PubMed ID: 17561874
[TBL] [Abstract][Full Text] [Related]
17. Potent inhibition of respiratory syncytial virus by combination treatment with 2-5A antisense and ribavirin.
Xu Z; Kuang M; Okicki JR; Cramer H; Chaudhary N
Antiviral Res; 2004 Mar; 61(3):195-206. PubMed ID: 15168801
[TBL] [Abstract][Full Text] [Related]
18. [Drugs active against respiratory viruses].
Freymuth F; Vabret A
Rev Prat; 1997 Mar; 47(6):646-51. PubMed ID: 9183939
[TBL] [Abstract][Full Text] [Related]
19. Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses.
Westover JB; Sefing EJ; Bailey KW; Van Wettere AJ; Jung KH; Dagley A; Wandersee L; Downs B; Smee DF; Furuta Y; Bray M; Gowen BB
Antiviral Res; 2016 Feb; 126():62-8. PubMed ID: 26711718
[TBL] [Abstract][Full Text] [Related]
20. Nucleoside analogue 2'-C-methylcytidine inhibits hepatitis E virus replication but antagonizes ribavirin.
Qu C; Xu L; Yin Y; Peppelenbosch MP; Pan Q; Wang W
Arch Virol; 2017 Oct; 162(10):2989-2996. PubMed ID: 28623406
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
